Dossier
appetite-controlling brain cells
Coverage of appetite-controlling brain cells in the Nexus archive.
- Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide triggers varied responses in appetite-controlling brain cells, explaining why GLP-1 weight-loss drugs like Ozempic and Wegovy lose effectiveness over time. Scientists also identified a potential method to prolong the drugs' efficacy, helping patients overcome weight-loss plateaus.